Literature DB >> 14645354

Postprandial hypertriglyceridaemia in patients with Tangier disease.

G Kolovou1, D Daskalova, K Anagnostopoulou, I Hoursalas, V Voudris, D P Mikhailidis, D V Cokkinos.   

Abstract

BACKGROUND: Tangier disease (TD) is the phenotypic expression of rare familial syndromes with mutations in the ABCA1 transporter. TD results in extremely low high density lipoprotein (HDL) cholesterol and reduced low density lipoprotein cholesterol, with normal or mildly increased fasting triglyceride (TG) concentrations. Although there is a close relation between HDL cholesterol values and atherogenesis, the risk of coronary artery disease is variable in TD. Raised fasting or postprandial TG values frequently accompany low HDL cholesterol and can add to the risk of a vascular event. AIMS: To investigate the postprandial TG response in TD. PATIENTS AND METHODS: Five patients (three homozygotes (HTD) and two heterozygotes (hTD)) from one family were studied. One was defined by DNA analysis as homozygous for a new mutation (C2033A) resulting in truncation of the ABCA1 protein. Their TG concentrations were measured before and four, six, and eight hours after a standardised fat load and compared with a control group.
RESULTS: Two patients with HTD had high fasting TG concentrations. The third patient with HTD, the two with hTD, and the control group had TG concentrations within the reference range. The patients with HTD had increased postprandial peak TG values when compared with those with hTD and controls.
CONCLUSION: Patients with HTD, with or without fasting hypertriglyceridaemia, may have an increased TG response to a fatty meal. The small number of patients does not allow definitive conclusions to be made. However, postprandial hypertriglyceridaemia could be a reason why some patients with TD develop premature atherosclerosis.

Entities:  

Mesh:

Year:  2003        PMID: 14645354      PMCID: PMC1770132          DOI: 10.1136/jcp.56.12.937

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

Review 1.  NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

Authors:  T Collins; M I Cybulsky
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risk In Communities (ARIC) study.

Authors:  A R Sharrett; G Heiss; L E Chambless; E Boerwinkle; S A Coady; A R Folsom; W Patsch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

4.  Lipoproteins and lipolytic plasma enzymes in a case of tangier disease.

Authors:  H Greten; T Hannemann; W Gusek; O Vivell
Journal:  N Engl J Med       Date:  1974-09-12       Impact factor: 91.245

Review 5.  Structure, function and regulation of the ABC1 gene product.

Authors:  G Schmitz; T Langmann
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

Review 6.  Postprandial triglycerides and endothelial function.

Authors:  A Jagla; J Schrezenmeir
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

Review 7.  Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

Authors:  H N Ginsberg; D R Illingworth
Journal:  Am J Cardiol       Date:  2001-09-20       Impact factor: 2.778

8.  Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates.

Authors:  J H Bae; E Bassenge; H J Lee; K R Park; C G Park; K Y Park; M S Lee; M Schwemmer
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

9.  Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography.

Authors:  M Jastrzebska; K Przybycień; K Chelstowski; B Torbus-Lisiecka; Z Kornacewicz-Jach; M Naruszewicz
Journal:  Nutr Metab Cardiovasc Dis       Date:  1999-02       Impact factor: 4.222

Review 10.  Recent findings in the study of postprandial lipemia.

Authors:  E J Parks
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

View more
  12 in total

Review 1.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

2.  Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-08       Impact factor: 4.698

3.  Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.

Authors:  Soonkyu Chung; Jenelle M Timmins; Myngan Duong; Chiara Degirolamo; Shunxing Rong; Janet K Sawyer; Roshni R Singaraja; Michael R Hayden; Nobuyo Maeda; Lawrence L Rudel; Gregory S Shelness; John S Parks
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

Review 4.  Hepatic ABC transporters and triglyceride metabolism.

Authors:  John S Parks; Soonkyu Chung; Gregory S Shelness
Journal:  Curr Opin Lipidol       Date:  2012-06       Impact factor: 4.776

5.  Platelet activating factor levels and metabolism in Tangier disease: a case study.

Authors:  Vana Kolovou; Vasiliki D Papakonstantinou; George Stamatakis; Sophia N Verouti; Marianna N Xanthopoulou; Genovefa Kolovou; Constantinos A Demopoulos
Journal:  Lipids Health Dis       Date:  2012-07-08       Impact factor: 3.876

6.  Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Antonis N Pavlidis; Klelia D Salpea; Stella A Iraklianou; Konstantinos Tsarpalis; Dimitris S Damaskos; Athanasios Manolis; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2005-09-30       Impact factor: 3.876

7.  Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.

Authors:  Genovefa D Kolovou; Katherine Anagnostopoulou; Nektarios D Pilatis; Klelia D Salpea; Ioannis S Hoursalas; Ilias Petropoulos; Helen I Bilianou; Dennis V Cokkinos
Journal:  Vasc Health Risk Manag       Date:  2005

8.  ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion.

Authors:  Xin Bi; Evanthia E Pashos; Marina Cuchel; Nicholas N Lyssenko; Mayda Hernandez; Antonino Picataggi; James McParland; Wenli Yang; Ying Liu; Ruilan Yan; Christopher Yu; Stephanie L DerOhannessian; Michael C Phillips; Edward E Morrisey; Stephen A Duncan; Daniel J Rader
Journal:  EBioMedicine       Date:  2017-03-14       Impact factor: 8.143

9.  The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-06-11

10.  Low fasting low high-density lipoprotein and postprandial lipemia.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Nektarios Pilatis; Nikolaos Kafaltis; Konstandina Sorodila; Eleftherios Psarros; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2004-07-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.